共 50 条
- [2] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in higher-grade meningiomas [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 469 - 470
- [4] P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas [J]. Acta Neuropathologica Communications, 11
- [6] Comparing loss of p16 and MTAP expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024,
- [7] Investigating the Use of p16 Immunohistochemistry as a Surrogate Marker for CDKN2A/B Homozygous Deletion in Astrocytomas [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 572 - 573
- [10] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546